While DRP1 is upregulated and activated in human and experimental PAH, MFN2 and its transcriptional coactivator PGC-1α are downregulated in IPAH, as well as in the MCT-PAH and Su/Hx-PAH models (Ryan et al., 2013). Here, DNM1L is linked to pulmonary arterial hypertension.